Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GFT-505 shows beneficial effect on plasma lipids

Dec. 2, 2008

ProStrakan grants license to Bayer Schering for Tostran testosterone treatment

Dec. 2, 2008

Increased glycosuria seen with dapagliflozin in type 2 diabetes studies

Dec. 1, 2008

Novel promising approach for treating diabetes discovered with JNK inhibition

Nov. 28, 2008

Pharming presents positive results from phase I Prodarsan study

Nov. 28, 2008

New antiobesity agents described in recent Schering-Plough patent

Nov. 28, 2008

Recent patents describe novel antidiabetic agents

Nov. 28, 2008

Aldose reductase inhibition lowers urinary albumin excretion in type 1 diabetes

Nov. 27, 2008

Advisory committee recommends FDA approval of febuxostat for gout

Nov. 27, 2008

Emisphere reports results from Novartis Pharma study of PTH-134 using Eligen technology

Nov. 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...